Association of methylphenidate use and traditional/cyberbullying - Tural Hesapcioglu S, Kandemir G.
This study aims to determine whether there is a difference in terms of traditional/cyberbullying or victimization among adolescents receiving methylphenidate for attention deficit hyperactivity disorder (ADHD) and treatment-na ïve adolescents w... (Source: SafetyLit)
Source: SafetyLit - February 8, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

The effects of methylphenidate on stress fractures in patients age 10-29: a national database study - DeFroda SF, Quinn M, Yang DS, Daniels AH, Owens BD.
This study further investigates this effect utilizing a large na... (Source: SafetyLit)
Source: SafetyLit - February 7, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Psychosocial functioning among college students who misuse stimulants versus other drugs - Cole VT, Hussong AM.
The misuse of prescription stimulants (e.g., Ritalin, Adderall) is a large and growing problem on college campuses. Emerging research examines not only the demographic predictors of stimulant misuse but also the potentially role that stimulant misuse plays... (Source: SafetyLit)
Source: SafetyLit - February 4, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Rich rewards: Scientists reveal ADHD medication's effect on the brain
(Okinawa Institute of Science and Technology (OIST) Graduate University) Researchers at the Okinawa Institute of Science and Technology Graduate University (OIST) have identified how certain areas of the human brain respond to methylphenidate -- a stimulant drug which is used to treat symptoms of ADHD. The work may help researchers understand the precise mechanism of the drug and ultimately develop more targeted medicines for the condition. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 17, 2020 Category: Biology Source Type: news

DTI-MRI links obesity to areas of white-matter damage
Diffusion-tensor MR images (DTI-MRI) have revealed signs of brain damage in...Read more on AuntMinnie.comRelated Reading: DTI-MRI shows varying results from football hits to head MRI links screen time to differences in kids' brains Can MRI of healthy brains explain head trauma damage? MRI shows effect of Ritalin on kids' brains Appetite controls disrupted in obese teens' brains (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 25, 2019 Category: Radiology Source Type: news

Q & A: A drug-free option for treating ADHD in children
Deciding how to treat attention deficit hyperactivity disorder in children can be a difficult decision for parents. Stimulants, such as Adderall and Ritalin, are the most commonly prescribed ADHD treatments — and are considered to be the most effective.   But in April, the FDA approved the first device-based, non-drug therapy to treat ADHD in children. The FDA decision followed the completion of aUCLA study demonstrating the effectiveness and safety of a trigeminal nerve stimulation device that could be a new option for treating the disorder.The device tested in the study was developed using technology inve...
Source: UCLA Newsroom: Health Sciences - November 5, 2019 Category: Universities & Medical Training Source Type: news

MRI links screen time to differences in kids' brains
Young children who spent more time in front of screens than recommended by...Read more on AuntMinnie.comRelated Reading: MRI shows effect of Ritalin on kids' brains Backlash mounts against study on smartphone 'horns' BBC: X-rays show signs of young adults growing 'horns' MRI exposes changes to kids' brains from football fMRI shows how game therapy 'rewires' ADHD brains (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 5, 2019 Category: Radiology Source Type: news

Medicines Supply Communications
Delmosart (methylphenidate) 18mg prolonged-release tablets The Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification for Delmosart (methylphenidate) 18mg prolonged-rel (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 1, 2019 Category: Drugs & Pharmacology Source Type: news

' Medium' Dose of Common ADHD Drug Most Effective for Kids'Medium' Dose of Common ADHD Drug Most Effective for Kids
Clinicians are being warned against overtreating children with methylphenidate, and to focus on neurocognitive function over behavior, based on results of a new meta-analysis.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 12, 2019 Category: Psychiatry Tags: Psychiatry News Source Type: news

Saffron is just as effective as Ritalin in managing symptoms of ADHD – study
(Natural News) Saffron (Crocus sativus) is gaining a lot of attention not just as an herb, but also as a natural treatment for brain health problems, including attention-deficit hyperactivity disorder (ADHD). In a recent study published in the Journal of Child and Adolescent Psychopharmacology, saffron was found to be just as effective as Ritalin in... (Source: NaturalNews.com)
Source: NaturalNews.com - September 9, 2019 Category: Consumer Health News Source Type: news

Study shows Ritalin and other ADHD drugs change the structure of children’s brains
(Natural News) When a child is diagnosed with ADHD, or attention-deficit/hyperactivity disorder, medication is often recommended. Profit-minded pharmaceutical companies and doctors hand these drugs out like candy, and some teachers even encourage it in hopes of having placated students who are easier to keep under control. Unfortunately, children often end up paying the price for... (Source: NaturalNews.com)
Source: NaturalNews.com - August 20, 2019 Category: Consumer Health News Source Type: news

DR MAX The Mind Doctor: Who on earth would want to be beautiful? (Yes, seriously!)
NHS psychiatrist Max Pemberton may make you rethink your life with his latest contemplations on everything from digital detoxes to the risks of Ritalin. (Source: the Mail online | Health)
Source: the Mail online | Health - August 17, 2019 Category: Consumer Health News Source Type: news

MRI shows effect of Ritalin on kids' brains
MR images indicate that methylphenidate, also known as Ritalin, can affect...Read more on AuntMinnie.comRelated Reading: fMRI shows how game therapy 'rewires' ADHD brains MRI shows smaller brain volume in kids with ADHD MR spectroscopy links ADHD drugs to positive emotions MRI, radiomics help diagnose, discern ADHD subtypes MRI links brain volume to ADHD (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 16, 2019 Category: Radiology Source Type: news

ADHD Drug Changes Kids' Brains, Maybe for the Better ADHD Drug Changes Kids' Brains, Maybe for the Better
A new study suggests that methylphenidate changes the brains of kids with attention-deficit/hyperactivity disorder. Could this be a good thing?Medscape (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - August 14, 2019 Category: Pediatrics Tags: Radiology Commentary Source Type: news

Common ADHD Medication May Affect Brain Development Common ADHD Medication May Affect Brain Development
Treatment with methylphenidate appears to affect the development of the brain's signal-carrying white matter in boys with ADHD, new research suggests.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - August 13, 2019 Category: Psychiatry Tags: Psychiatry News Source Type: news

Commonly prescribed ADHD drug Ritalin 'affects brain development in children'
Ritalin, the brand name for methylphenidate, focuses the brain. A Dutch study using MRI scans showed children had less white matter in the brain while taking the drug. (Source: the Mail online | Health)
Source: the Mail online | Health - August 13, 2019 Category: Consumer Health News Source Type: news

ADHD Medication Methylphenidate May Alter Boys' Brains
TUESDAY, Aug. 13, 2019 -- One of the most popular and effective medications used to treat attention-deficit/hyperactivity disorder (ADHD) appears to alter the brains of boys with the disorder, a new study shows. While the researchers couldn't say... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 13, 2019 Category: General Medicine Source Type: news

Methylphenidate Treatment Tied to Brain Changes in Boys With ADHD
TUESDAY, Aug. 13, 2019 -- Treatment with methylphenidate (MPH) affects specific tracts in brain white matter in boys with attention-deficit/hyperactivity disorder (ADHD), according to a study published online Aug. 13 in Radiology. Cheima Bouziane,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 13, 2019 Category: Pharmaceuticals Source Type: news

Medical News Today: Concerta vs. Vyvanse for ADHD
Concerta and Vyvanse are two stimulant medications that can help treat ADHD. In this article, learn about how they work, as well as their possible side effects. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 17, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Medical News Today: Everything you need to know about methylphenidate
Methylphenidate is a stimulant drug that doctors prescribe to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. Learn about how it works, its side effects, and typical dosages here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 12, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Medical News Today: What to know about the Concerta crash
Concerta is a stimulant medication that helps treat the symptoms of ADHD. As the drug leaves the body, a person may experience fatigue or depression. People call this the ‘Concerta crash.’ Learn about causes and prevention here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 5, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Medical News Today: Everything you need to know about Concerta
Concerta is a type of medication that doctors sometimes prescribe to treat attention deficit hyperactivity disorder (ADHD). It is a slow-release medication, meaning that if a person takes one pill in the morning, it will release the drug into the body throughout the day. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 5, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Medical News Today: What is the difference between Concerta and Ritalin?
Concerta and Ritalin are both prescription drugs containing the active ingredient methylphenidate hydrochloride. Learn about the differences between them here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 4, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study - Hollis C, Chen Q, Chang Z, Quinn PD, Viktorin A, Lichtenstein P, D'Onofrio B, Land én M, Larsson H.
BACKGROUND: There is a clinical concern that prescribing methylphenidate, the most common pharmacological treatment for attention-deficit hyperactivity disorder (ADHD), might increase the risk of psychotic events, particularly in young people with a histor... (Source: SafetyLit)
Source: SafetyLit - June 26, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Jornay PM (Methylphenidate Hydrochloride Extended-release Capsules ) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 3, 2019 Category: Drugs & Pharmacology Source Type: news

Medical News Today: What are the side effects and risks of Ritalin?
Ritalin (methylphenidate) is a stimulant medication for the treatment of ADHD and narcolepsy. Ritalin can cause side effects and has the potential for misuse and addiction. Researchers are investigating the long-term safety and effectiveness of this drug in children and adolescents. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 31, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Natural treatment for ADHD: Saffron may be as effective as medical stimulants
(Natural News) If you or a loved one suffers from attention deficit hyperactivity disorder (ADHD), or perhaps some undiagnosed variation of such that simply makes it difficult to focus on the task at hand, don’t reach for the Ritalin just yet. New research out of Iran suggests that saffron (Crocus sativus L.), one of the... (Source: NaturalNews.com)
Source: NaturalNews.com - May 29, 2019 Category: Consumer Health News Source Type: news

The association between attention-deficit hyperactivity disorder, injuries, and methylphenidate - Shem-Tov S, Chodick G, Weitzman D, Koren G.
Objective. To evaluate the relationship between attention-deficit hyperactivity disorder (ADHD) and injuries and to verify whether methylphenidate (MPH), is associated with decreasing the risk of injuries. Methods. A retrospective cohort ... (Source: SafetyLit)
Source: SafetyLit - May 26, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Methylphenidate Capsules for Morning ADHD Symptom Control Methylphenidate Capsules for Morning ADHD Symptom Control
Newly approved delayed- and extended-release methylphenidate capsules designed for bedtime administration may provide better early morning symptom control for ADHD patients.Pediatric Pharmacotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2019 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Amid America's opioid crisis, deaths from stimulants are steadily rising
Overdose deaths involving cocaine and psychotstimulants such as methamphematines, MDMA, methylphenidate (commonly sold as Ritalin) and caffeine have been steadily rising, according to a new report from the US Centers for Disease Control and Prevention. (Source: CNN.com - Health)
Source: CNN.com - Health - May 2, 2019 Category: Consumer Health News Source Type: news

Lannett To Launch Generic Concerta(R), AB-rated Methylphenidate Hydrochloride ER Tablets
PHILADELPHIA, April 30, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it expects to launch later this quarter Methylphenidate Hydrochloride Extended Release (ER) tablets USP (CII) in 18 mg, 27 mg,... Biopharmaceuticals, Generics, Product Launch Lannett, Concerta , Methylphenidate (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 30, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves First Medical Device To Treat ADHD In Children
(CNN) — The first medical device to treat childhood attention deficit hyperactivity disorder, or ADHD, was OK’d Friday by the US Food and Drug Administration. Designated for children ages 7 to 12 who are not currently on medication for the disorder, the device delivers a low-level electrical pulse to the parts of the brain responsible for ADHD symptoms. “This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” Carlos Peña, director of the Division of Neurological and Physical Medicine Devices in...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 22, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN ADHD Source Type: news

Medical News Today: Concerta vs. Adderall: What's the difference?
Concerta and Adderall are both medications that can help treat the symptoms of attention deficit hyperactivity disorder (ADHD). Learn about the differences between them and the possible side effects in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 10, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Medical News Today: Ritalin vs. Adderall: What's the difference?
Ritalin and Adderall are different types of stimulant medication that doctors can prescribe to help treat ADHD. Learn about the differences between them and the possible side effects here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 10, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Might microdosing psychedelics be safe and beneficial? An initial exploration - Fadiman J, Korb S.
Albert Hoffman suggested that low doses of LSD might be an appropriate alternative to Ritalin. Following this possibility, a systematic exploration of the effects of "microdoses," comprising hundreds of lengthy descriptive reports, was undertaken. Based on... (Source: SafetyLit)
Source: SafetyLit - April 4, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Can delayed/extended-release methylphenidate allow for once daily evening dosing in ADHD?
(Mary Ann Liebert, Inc./Genetic Engineering News) A new three-part study showed that a delayed-release, extended-release form of methylphenidate could be given to adults in the evening with or without food and would not exert any clinically meaningful effect for at least 10 hours after administration. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 2, 2019 Category: International Medicine & Public Health Source Type: news

ANI Pharmaceuticals Announces Two Generic Product Launches
BAUDETTE, Minn., March 27, 2019 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced the launch of 18mg and 27mg Methylphenidate Hydrochloride Extended-Release T... Biopharmaceuticals, Generics, Product Launch ANI Pharmaceuticals, Methylphenidate, Attention Deficit Hyperactivity Disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 27, 2019 Category: Pharmaceuticals Source Type: news

Childhood methylphenidate treatment predicts antidepressant use during adolescence
(Bar-Ilan University) A new, 12-year longitudinal study, which monitored 6,830 children from early childhood into adolescence, has shown that consistent treatment with MPH-based medications during childhood increases the risk of antidepressant use during adolescence. The study is the first of its kind to examine the connection between children diagnosed with ADHD and prescribed MPH between the ages of six and eight, and future dispensed prescriptions of antidepressants. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 27, 2019 Category: International Medicine & Public Health Source Type: news

Psychosis Risk Varies With ADHD Meds, Still Small
In the study, people who took amphetamines, like Adderall and Vyvanse, seemed to carry a relatively greater risk than the methylphenidates Ritalin and Concerta. (Source: WebMD Health)
Source: WebMD Health - March 21, 2019 Category: Consumer Health News Source Type: news

In Youth With ADHD, New-Onset Psychosis Up With Amphetamines
THURSDAY, March 21, 2019 -- For adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD), new-onset psychosis occurs more often with amphetamine use versus methylphenidate use, according to a study published in the March 21... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Young people on amphetamines for ADHD have twice the psychosis risk compared to other stimulants, study says
Teens and young adults with attention deficit-hyperactivity disorder, ADHD, who receive amphetamines such as Adderall for treatment have a higher risk of developing psychosis, compared to those who receive methyphenidates stimulants, such as Ritalin, according to a large new study. (Source: CNN.com - Health)
Source: CNN.com - Health - March 20, 2019 Category: Consumer Health News Source Type: news

Some ADHD Meds Tied to a Higher Psychosis Risk Than Others Some ADHD Meds Tied to a Higher Psychosis Risk Than Others
Amphetamines are associated with a higher psychosis risk than methylphenidate in young patients who take these agents to treat attention deficit hyperactivity disorder.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - March 20, 2019 Category: Primary Care Tags: Psychiatry News Source Type: news

With ADHD, amphetamine has double the psychosis risk of methylphenidate
(Reuters Health) - Children and young adults with attention deficit-hyperactivity disorder (ADHD) who are treated with the stimulants amphetamine or methylphenidate face a small but significant risk of developing psychosis, with amphetamine products twice as likely to spark at problem, researchers say. (Source: Reuters: Health)
Source: Reuters: Health - March 20, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Popular Spice Rivals Stimulant for ADHD Popular Spice Rivals Stimulant for ADHD
The popular and expensive spice saffron appears to be as effective as the stimulant methylphenidate in treating symptoms in youngsters with ADHD, new research suggests.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 11, 2019 Category: Psychiatry Tags: Psychiatry News Source Type: news

Adhansia XR (Methylphenidate Hydrochloride Extended-release Capsules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 7, 2019 Category: Drugs & Pharmacology Source Type: news

FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD
STAMFORD, Conn.--(BUSINESS WIRE) March 01, 2019 --Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced that the U.S. Food and Drug Administration (FDA) approved Adhansia XR (methylphenidate hydrochloride) extended-release capsules... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 1, 2019 Category: Drugs & Pharmacology Source Type: news

Nootropics, or ‘Smart Drugs,’ Are Gaining Popularity. But Should You Take Them?
The idea that a pill can supersize human intelligence is decidedly science fiction. But plenty of real-world researchers and drug-makers are working to develop nootropics: pills, supplements and other substances designed to improve various aspects of cognition. A rough translation for the word “nootropic” comes from the Greek for “to bend or shape the mind.” And already, there are dozens of over-the-counter (OTC) products—many of which are sold widely online or in stores—that claim to boost creativity, memory, decision-making or other high-level brain functions. Some of the most popular ...
Source: TIME: Health - January 23, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Drugs Source Type: news

Animal Study Suggests Ritalin Won't Harm the Heart
Title: Animal Study Suggests Ritalin Won't Harm the HeartCategory: Health NewsCreated: 1/9/2019 12:00:00 AMLast Editorial Review: 1/10/2019 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - January 10, 2019 Category: Pediatrics Source Type: news

Animal Study Suggests Ritalin Won't Harm the Heart
WEDNESDAY, Jan. 9, 2019 -- Ritalin, a widely used stimulant drug to treat attention-deficit/hyperactivity disorder (ADHD), likely poses no risk of heart damage in children, new research in monkeys suggests. The findings are " very reassuring, " said... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 9, 2019 Category: General Medicine Source Type: news

Ritalin drives greater connection between brain areas key to memory, attention
(University of Wisconsin-Madison) Louis Populin and collaborators at the University of Wisconsin-Madison collaborators published a study this week in the Journal of Neuroscience describing increased connections between key parts of the brains of monkeys who have taken methylphenidate (Ritalin). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 12, 2018 Category: International Medicine & Public Health Source Type: news